Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

News from APA: Adderall has significant advantages over Ritalin in treatment of ADHD

May 27, 1999

Dopaminergic and serotonergic ligands in development at Sanofi-Synthelabo

May 27, 1999

Antalarmin suppresses stress-related behavior in nonhuman primate model

May 27, 1999

Cephalon's narcolepsy treatment available in Austria

May 27, 1999

CoCensys and Parke-Davis collaboration yields development compound

May 27, 1999

Fluvoxamine maleate launched in Japan for social anxiety disorder

May 26, 1999

Yoshitomi discloses new antipsychotics in recent patent literature

May 26, 1999

Ortho-McNeil describes new dipyridoimidazole series of GABA-A receptor ligands

May 26, 1999

NeuroSearch-Meiji Seika team discovers positive modulators of GABA-A receptor complex

May 26, 1999

Cortex receives SBIR grant for new stroke therapy

May 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...